William (PFO) compensation by year
Akero Therapeutics Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $452,000 |
| Bonus | $0 |
| Stock awards | $824,425 |
| Option awards | $2,556,818 |
| Non-equity incentive | $316,400 |
| Pension and deferred compensation | $0 |
| All other | $0 |
| Total | $4,149,643 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Akero Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0000950170-25-058964, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Akero Therapeutics, Inc. filed document, accession 0000950170-25-058964. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.
Akero Therapeutics’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Andrew Cheng | President and Chief Executive Officer | $10,446,243 |
| William (PFO) · this page | Chief Financial Officer | $4,149,643 |
| Jonathan Young | Chief Operating Officer | $4,144,543 |
| Catriona Yale | Chief Development Officer | $4,136,043 |
The full Akero Therapeutics compensation record
free company briefThis page is one person within Akero Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Akero Therapeutics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Akero Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.